AI in radiological imaging of soft-tissue and bone tumours: a systematic review evaluating against CLAIM and FUTURE-AI guidelines
0
🤖
Sign in to get full access
Overview
- Soft-tissue and bone tumors (STBT) are rare and diagnostically challenging lesions with varying clinical behaviors and treatment approaches.
- This systematic review examines the use of Artificial Intelligence (AI) methods using radiological imaging for diagnosing and predicting the prognosis of these tumors.
- The review highlights challenges in translating these AI methods to clinical practice and evaluates their alignment with two sets of guidelines: the Checklist for AI in Medical Imaging (CLAIM) and the FUTURE-AI international consensus guidelines.
Plain English Explanation
Soft-tissue and bone tumors are uncommon growths that can be difficult for doctors to diagnose and treat. This review looks at how artificial intelligence (AI) systems using medical imaging data can be used to help diagnose these tumors and predict how they might progress. The review discusses the challenges in getting these AI tools to actually be used in clinics and hospitals, and it evaluates how well the AI research in this area aligns with two sets of guidelines designed to ensure AI systems are trustworthy and ready for real-world use.
Technical Explanation
The researchers conducted a systematic review of the literature on using AI methods and radiological imaging to diagnose and predict the prognosis of soft-tissue and bone tumors. They searched several databases for relevant peer-reviewed studies published before July 2024, excluding animal, cadaver, or non-English studies.
After screening 15,015 abstracts, the team included 325 articles in their evaluation. They assessed these studies against the CLAIM and FUTURE-AI guidelines, which provide criteria for ensuring AI systems are designed, developed, evaluated, and deployed appropriately for medical use.
Critical Analysis
The review found that while the AI tools for STBT diagnosis and prognosis showed promise, they are still largely at the proof-of-concept stage. The studies scored moderately on the CLAIM guidelines (average of 28.9 out of 53) but poorly on the FUTURE-AI guidelines (average of 5.1 out of 30).
This indicates there is significant room for improvement in areas like defining the unmet clinical need, intended setting, and workflow integration, building on previous work, ensuring explainability, evaluating and addressing biases, and making code and data publicly available.
Conclusion
This systematic review highlights the potential of AI methods using radiological imaging for diagnosing and predicting the prognosis of soft-tissue and bone tumors. However, it also identifies significant challenges in translating these AI tools to clinical practice. By following recommendations around design, development, evaluation, and data availability, future research in this area could help improve the real-world applicability of these AI systems.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
🤖
0
AI in radiological imaging of soft-tissue and bone tumours: a systematic review evaluating against CLAIM and FUTURE-AI guidelines
Douwe J. Spaanderman (Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands), Matthew Marzetti (Department of Medical Physics, Leeds Teaching Hospitals NHS Trust, UK, Leeds Biomedical Research Centre, University of Leeds, UK), Xinyi Wan (Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands), Andrew F. Scarsbrook (Department of Radiology, Leeds Teaching Hospitals NHS Trust, UK, Leeds Institute of Medical Research, University of Leeds, UK), Philip Robinson (Department of Radiology, Leeds Teaching Hospitals NHS Trust, UK), Edwin H. G. Oei (Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands), Jacob J. Visser (Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands), Robert Hemke (Department of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, the Netherlands), Kirsten van Langevelde (Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands), David F. Hanff (Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands), Geert J. L. H. van Leenders (Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands), Cornelis Verhoef (Department of Surgical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands), Dirk J. Gruuhagen (Department of Surgical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands), Wiro J. Niessen (Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands, Faculty of Medical Sciences, University of Groningen, Groningen, the Netherlands), Stefan Klein (Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands), Martijn P. A. Starmans (Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands)
Soft-tissue and bone tumours (STBT) are rare, diagnostically challenging lesions with variable clinical behaviours and treatment approaches. This systematic review provides an overview of Artificial Intelligence (AI) methods using radiological imaging for diagnosis and prognosis of these tumours, highlighting challenges in clinical translation, and evaluating study alignment with the Checklist for AI in Medical Imaging (CLAIM) and the FUTURE-AI international consensus guidelines for trustworthy and deployable AI to promote the clinical translation of AI methods. The review covered literature from several bibliographic databases, including papers published before 17/07/2024. Original research in peer-reviewed journals focused on radiology-based AI for diagnosing or prognosing primary STBT was included. Exclusion criteria were animal, cadaveric, or laboratory studies, and non-English papers. Abstracts were screened by two of three independent reviewers for eligibility. Eligible papers were assessed against guidelines by one of three independent reviewers. The search identified 15,015 abstracts, from which 325 articles were included for evaluation. Most studies performed moderately on CLAIM, averaging a score of 28.9$pm$7.5 out of 53, but poorly on FUTURE-AI, averaging 5.1$pm$2.1 out of 30. Imaging-AI tools for STBT remain at the proof-of-concept stage, indicating significant room for improvement. Future efforts by AI developers should focus on design (e.g. define unmet clinical need, intended clinical setting and how AI would be integrated in clinical workflow), development (e.g. build on previous work, explainability), evaluation (e.g. evaluating and addressing biases, evaluating AI against best practices), and data reproducibility and availability (making documented code and data publicly available). Following these recommendations could improve clinical translation of AI methods.
Read more8/23/2024
🗣️
0
Artificial Intelligence in Bone Metastasis Analysis: Current Advancements, Opportunities and Challenges
Marwa Afnouch, Fares Bougourzi, Olfa Gaddour, Fadi Dornaika, Abdelmalik Taleb-Ahmed
In recent years, Artificial Intelligence (AI) has been widely used in medicine, particularly in the analysis of medical imaging, which has been driven by advances in computer vision and deep learning methods. This is particularly important in overcoming the challenges posed by diseases such as Bone Metastases (BM), a common and complex malignancy of the bones. Indeed, there have been an increasing interest in developing Machine Learning (ML) techniques into oncologic imaging for BM analysis. In order to provide a comprehensive overview of the current state-of-the-art and advancements for BM analysis using artificial intelligence, this review is conducted with the accordance with PRISMA guidelines. Firstly, this review highlights the clinical and oncologic perspectives of BM and the used medical imaging modalities, with discussing their advantages and limitations. Then the review focuses on modern approaches with considering the main BM analysis tasks, which includes: classification, detection and segmentation. The results analysis show that ML technologies can achieve promising performance for BM analysis and have significant potential to improve clinician efficiency and cope with time and cost limitations. Furthermore, there are requirements for further research to validate the clinical performance of ML tools and facilitate their integration into routine clinical practice.
Read more5/1/2024
📈
0
Artificial Intelligence Model for Tumoral Clinical Decision Support Systems
Guillermo Iglesias, Edgar Talavera, Jes'us Troya Garc`ia, Alberto D'iaz-'Alvarez, Miguel Grac'ia-Remesal
Comparative diagnostic in brain tumor evaluation makes possible to use the available information of a medical center to compare similar cases when a new patient is evaluated. By leveraging Artificial Intelligence models, the proposed system is able of retrieving the most similar cases of brain tumors for a given query. The primary objective is to enhance the diagnostic process by generating more accurate representations of medical images, with a particular focus on patient-specific normal features and pathologies. The proposed model uses Artificial Intelligence to detect patient features to recommend the most similar cases from a database. The system not only suggests similar cases but also balances the representation of healthy and abnormal features in its design. This not only encourages the generalization of its use but also aids clinicians in their decision-making processes. We conducted a comparative analysis of our approach in relation to similar studies. The proposed architecture obtains a Dice coefficient of 0.474 in both tumoral and healthy regions of the patients, which outperforms previous literature. Our proposed model excels at extracting and combining anatomical and pathological features from brain glspl{mr}, achieving state-of-the-art results while relying on less expensive label information. This substantially reduces the overall cost of the training process. This paper provides substantial grounds for further exploration of the broader applicability and optimization of the proposed architecture to enhance clinical decision-making. The novel approach presented in this work marks a significant advancement in the field of medical diagnosis, particularly in the context of Artificial Intelligence-assisted image retrieval, and promises to reduce costs and improve the quality of patient care using Artificial Intelligence as a support tool instead of a black box system.
Read more5/27/2024
🖼️
0
An updated overview of radiomics-based artificial intelligence (AI) methods in breast cancer screening and diagnosis
Reza Elahi, Mahdis Nazari
Current imaging methods for diagnosing BC are associated with limited sensitivity and specificity and modest positive predictive power. The recent progress in image analysis using artificial intelligence (AI) has created great promise to improve breast cancer (BC) diagnosis and subtype differentiation. In this case, novel quantitative computational methods, such as radiomics, have been developed to improve the sensitivity and specificity of early BC diagnosis and classification. The potential of radiomics in improving the diagnostic efficacy of imaging studies has been shown in several studies. In this review article, we discuss the radiomics workflow and current hand-crafted radiomics methods in the diagnosis and classification of BC based on most recent studies on different imaging modalities, e.g. MRI, mammography, contrast-enhanced spectral mammography (CESM), ultrasound imaging, and digital breast tumosynthesis (DBT). We also discuss current challenges and potential strategies to improve the specificity and sensitivity of radiomics in breast cancer to help achieve a higher level of BC classification and diagnosis in the clinical setting. The growing field of AI incorporation with imaging information has opened a great opportunity to provide a higher level of care for BC patients.
Read more6/24/2024